Human NPFF2 Receptor ELISA Kit (A75659) employs the competitive enzyme immunoassay technique for the quantitative measurement of human NPFF2 Receptor in serum, plasma, tissue homogenates, and other biological fluids. The 96-well microtiter plate has been pre-coated with NPFF2 Receptor antigen. During the incubation, NPFF2 Receptor present in the samples or standards competes with the fixed amount of immobilized NPFF2 Receptor for binding sites on the Biotinylated Anti-NPFF2 Receptor Antibody. The more NPFF2 Receptor present in a sample or standard, the less Biotinylated Anti-NPFF2 Receptor Antibody that binds to the plate. Following incubation, unbound Biotinylated Anti-NPFF2 Receptor Antibody is removed by washing, and an HRP-Streptavidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is inversely proportional to the amount of NPFF2 Receptor present in each sample or standard. The concentration of NPFF2 Receptor can then be calculated by reading the O.D. absorbance at 450nm in a microplate reader and referring to the standard curve.